Outpatient Treatment of Low-risk Pulmonary Embolism (Low Risk PE)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02355548|
Recruitment Status : Completed
First Posted : February 4, 2015
Last Update Posted : November 29, 2018
|Condition or disease||Intervention/treatment|
|Pulmonary Embolism||Other: Outpatient Treatment of Pulmonary Embolism|
|Study Type :||Observational|
|Estimated Enrollment :||200 participants|
|Official Title:||Rapid Risk Stratification for Outpatient Treatment of Low-risk Pulmonary Embolism|
|Study Start Date :||December 2012|
|Actual Primary Completion Date :||December 2017|
|Actual Study Completion Date :||December 2017|
All patients eligible for the study will have their PE treated in the outpatient setting.
Other: Outpatient Treatment of Pulmonary Embolism
Patients who participate in the study will be treated for their pulmonary embolism in an outpatient setting instead of being hospitalized.
- 90-day all-cause mortality, recurrent VTE, and Major Bleeding during outpatient treatment of Low-risk PE [ Time Frame: 90 Days ]This is a composite outcome of the above.
- Reduction of medical costs due to outpatient treatment. [ Time Frame: 90 Days ]
- Level of patient satisfaction as measured by survey. [ Time Frame: 90 Days Post study enrollment ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02355548
|United States, Utah|
|Intermountain Medical Center|
|Murray, Utah, United States, 84157|
|Principal Investigator:||Joseph Bledsoe, MD||Intermountain Health Care, Inc.|